Intranasal submucosal application of Bevacizumab in hereditary hemorrhagic telangiectasia (HHT) – the effect on endothelial cell proliferation and VEGF expression – an in vitro study - Schäfer, E; Rotter, N; Häussler, D; Sadick, H (Laryngo-Rhino-Otologie, 2020)